[P3-402]: PATIENTS WITH SUBJECTIVE COGNITIVE DECLINE AND AMYLOID PATHOLOGY EXHIBIT SIGNIFICANT BRAIN ATROPHY, TAU PATHOLOGY AND MILD MEMORY DIFFICULTIES

2017 ◽  
Vol 13 (7S_Part_23) ◽  
pp. P1117-P1117
Author(s):  
Olof Lindberg ◽  
Erik Stomrud ◽  
Oskar Hansson
2016 ◽  
Vol 12 ◽  
pp. P102-P103
Author(s):  
Alexa Pichet Binette ◽  
Jacob W. Vogel ◽  
Vladimir S. Fonov ◽  
Cécile Madjar ◽  
Jennifer Tremblay-Mercier ◽  
...  

2015 ◽  
Vol 11 (7S_Part_7) ◽  
pp. P315-P316
Author(s):  
Jacob W. Vogel ◽  
Monika Varga Doležalová ◽  
Renaud La Joie ◽  
Shawn Marks ◽  
Allison Fero ◽  
...  

2019 ◽  
Vol 15 (7) ◽  
pp. P143-P144
Author(s):  
Denise Visser ◽  
Rik Ossenkoppele ◽  
Sander C.J. Verfaillie ◽  
Tessa Timmers ◽  
Emma E. Wolters ◽  
...  

Neurology ◽  
2019 ◽  
Vol 92 (5) ◽  
pp. e395-e405
Author(s):  
Olga Voevodskaya ◽  
Konstantinos Poulakis ◽  
Pia Sundgren ◽  
Danielle van Westen ◽  
Sebastian Palmqvist ◽  
...  

ObjectiveTo investigate the association between longitudinal changes in proton magnetic resonance spectroscopy (MRS) metabolites and amyloid pathology in individuals without dementia, and to explore the relationship between MRS and cognitive decline.MethodsIn this longitudinal multiple time point study (a subset of the Swedish BioFINDER), we included cognitively healthy participants, individuals with subjective cognitive decline, and individuals with mild cognitive impairment. MRS was acquired serially in 294 participants (670 individual spectra) from the posterior cingulate/precuneus. Using mixed-effects models, we assessed the association between MRS and baseline β-amyloid (Aβ), and between MRS and the longitudinal Mini-Mental State Examination, accounting for APOE, age, and sex.ResultsWhile baseline MRS metabolites were similar in Aβ positive (Aβ+) and negative (Aβ−) individuals, in the Aβ+ group, the estimated rate of change was +1.9%/y for myo-inositol (mI)/creatine (Cr) and −2.0%/y for N-acetylaspartate (NAA)/mI. In the Aβ− group, mI/Cr and NAA/mI yearly change was −0.05% and +1.2%; however, this was not significant across time points. The mild cognitive impairment Aβ+ group showed the steepest MRS changes, with an estimated rate of +2.93%/y (p = 0.07) for mI/Cr and −3.55%/y (p < 0.01) for NAA/mI. Furthermore, in the entire cohort, we found that Aβ+ individuals with low baseline NAA/mI had a significantly higher rate of cognitive decline than Aβ+ individuals with high baseline NAA/mI.ConclusionWe demonstrate that the longitudinal change in mI/Cr and NAA/mI is associated with underlying amyloid pathology. MRS may be a useful noninvasive marker of Aβ-related processes over time. In addition, we show that in Aβ+ individuals, baseline NAA/mI may predict the rate of future cognitive decline.


2019 ◽  
Vol 11 (1) ◽  
Author(s):  
Lisa Miebach ◽  
Steffen Wolfsgruber ◽  
Alexandra Polcher ◽  
Oliver Peters ◽  
Felix Menne ◽  
...  

2019 ◽  
Vol 15 ◽  
pp. P1433-P1434
Author(s):  
Sietske A.M. Sikkes ◽  
Jennifer R. Gatchel ◽  
Rachel F. Buckley ◽  
Mark A. van de Wiel ◽  
Dorene M. Rentz ◽  
...  

2019 ◽  
Vol 15 ◽  
pp. P1412-P1413
Author(s):  
Denise Visser ◽  
Rik Ossenkoppele ◽  
Sander C.J. Verfaillie ◽  
Tessa Timmers ◽  
Emma E. Wolters ◽  
...  

2016 ◽  
Vol 12 ◽  
pp. P939-P940
Author(s):  
Alexa Pichet Binette ◽  
Jacob W. Vogel ◽  
Vladimir S. Fonov ◽  
Jennifer Tremblay-Mercier ◽  
Cécile Madjar ◽  
...  

2021 ◽  
pp. 102923
Author(s):  
Cassandra Morrison ◽  
Mahsa Dadar ◽  
Neda Shafiee ◽  
Sylvia Villeneuve ◽  
D. Louis Collins

Sign in / Sign up

Export Citation Format

Share Document